Adrian Iaina

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

Mona Boaz, Shmuel Smetana, Talia Weinstein et al. · The Lancet · 2000 · 1K citations

Urology, Renal Disease, Renal Function +11

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

Donald S. Silverberg, Dov Wexler, Miriam Blum et al. · Journal of the American College of Cardiology · 2000 · 726 citations

Anemia, Subcutaneous Erythropoietin, Heart Failure +12

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

Donald S. Silverberg, Dov Wexler, David S. Sheps et al. · Journal of the American College of Cardiology · 2001 · 642 citations

Anemia, Subcutaneous Erythropoietin, Heart Failure +11

Randomised crossover trial of naltrexone in uraemic pruritus

Gary Peer, Shmuel Kivity, O. Agami et al. · The Lancet · 1996 · 295 citations

Urological Research, Urology, Crossover Trial +2

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years

M Weintraub, Itamar Grosskopf, T. Rassin et al. · BMJ · 1996 · 217 citations · Full text